DK0587723T3 - quinuclidine derivatives - Google Patents

quinuclidine derivatives

Info

Publication number: DK0587723T3
Authority: DK; Denmark
Prior art keywords: quinuclidine derivatives; quinuclidine; derivatives
Prior art date: 1991-05-31

Application number

DK92912601.9T

Other languages

Danish (da)

Inventor

John Adams Lowe Iii

Fumitaka Ito

Hiroshi Kondo

Kaoru Shimada

Masami Nakane

Terry Jay Rosen

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-05-31

Filing date

1992-04-28

Publication date

1996-04-01

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24845673&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0587723(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1992-04-28 Application filed by Pfizer filed Critical Pfizer

1996-04-01 Application granted granted Critical

1996-04-01 Publication of DK0587723T3 publication Critical patent/DK0587723T3/en

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Anesthesiology (AREA)
Psychiatry (AREA)
Gastroenterology & Hepatology (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

DK92912601.9T 1991-05-31 1992-04-28 quinuclidine derivatives DK0587723T3 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US70840491A	1991-05-31	1991-05-31

Publications (1)

Publication Number	Publication Date
DK0587723T3 true DK0587723T3 (en)	1996-04-01

Family

ID=24845673

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK92912601.9T DK0587723T3 (en)	1991-05-31	1992-04-28	quinuclidine derivatives

Country Status (41)

Country	Link
US (3)	US5807867A (en)
EP (1)	EP0587723B1 (en)
JP (2)	JPH0733386B2 (en)
KR (1)	KR100214905B1 (en)
CN (1)	CN1048492C (en)
AP (1)	AP299A (en)
AT (1)	ATE135006T1 (en)
AU (1)	AU657552B2 (en)
BG (1)	BG61694B1 (en)
BR (1)	BR9206073A (en)
CA (1)	CA2102179C (en)
CZ (1)	CZ281403B6 (en)
DE (4)	DE69208877T2 (en)
DK (1)	DK0587723T3 (en)
EG (1)	EG19944A (en)
ES (1)	ES2084361T3 (en)
FI (1)	FI114475B (en)
GR (1)	GR3019687T3 (en)
GT (1)	GT199200028A (en)
HU (1)	HU217548B (en)
IE (1)	IE72473B1 (en)
IL (1)	IL102008A (en)
IS (1)	IS1611B (en)
LU (1)	LU91293I2 (en)
MA (1)	MA22539A1 (en)
MX (1)	MX9202554A (en)
NL (1)	NL300250I2 (en)
NO (2)	NO302701B1 (en)
NZ (2)	NZ242956A (en)
OA (1)	OA09867A (en)
PL (1)	PL171379B1 (en)
PT (1)	PT100546B (en)
RO (1)	RO110499B1 (en)
RU (1)	RU2103269C1 (en)
SK (1)	SK390692A3 (en)
TW (1)	TW204349B (en)
UA (1)	UA27776C2 (en)
UY (1)	UY23422A1 (en)
WO (1)	WO1992021677A1 (en)
YU (1)	YU48995B (en)
ZA (1)	ZA923942B (en)

Families Citing this family (88)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992021677A1 (en) *	1991-05-31	1992-12-10	Pfizer Inc.	bibNUCLIDINE DERIVATIVES
EP0589924B1 (en) *	1991-06-20	1996-09-04	Pfizer Inc.	Fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
EP0655996B1 (en) *	1992-08-19	2001-11-07	Pfizer Inc.	Substituted benzylamino nitrogen containing non-aromatic heterocycles
JP2668164B2 (en) *	1992-11-12	1997-10-27	ファイザー・インク．	Quinuclidine derivative as substance P antagonist
US5344830A (en) *	1992-12-10	1994-09-06	Merck & Co., Inc.	N,N-diacylpiperazine tachykinin antagonists
JP2822274B2 (en) *	1993-05-19	1998-11-11	ファイザー製薬株式会社	Heteroatom-substituted alkylbenzylaminoquinuclidines as substance P antagonists
IL109646A0 (en) *	1993-05-19	1994-08-26	Pfizer	Heteroatom substituted alkyl benzylamino-quinuclidines
US5393762A (en) *	1993-06-04	1995-02-28	Pfizer Inc.	Pharmaceutical agents for treatment of emesis
EP0653208A3 (en) *	1993-11-17	1995-10-11	Pfizer	Substance P antagonists for the treatment and prevention of solar erythema.
EP0659409A3 (en) *	1993-11-23	1995-08-09	Pfizer	Substance P antagonists to inhibit angiogenesis.
EP0655246A1 (en) *	1993-11-30	1995-05-31	Pfizer Inc.	Substance P antagonists for the treatment of disorders caused by helicobacter pylori or other spiral urease-positive gram-negative bacteria
IL116249A (en) *	1994-12-12	2003-07-06	Pfizer	Nk-1 receptor antagonists for the treatment of neuronal damage and stroke
PE8798A1 (en) *	1995-07-17	1998-03-02	Pfizer	PROCEDURE FOR SEPARATION OF ENANTIOMERS FROM 1-AZABICICLO [2.2.2] OCTAN-3-AMINE, 2- (DIPHENYL METHYL) -N- [[2-METOXY-5- (1-METHYLETHYL) PHENYL] METHYL]
TW458774B (en)	1995-10-20	2001-10-11	Pfizer	Antiemetic pharmaceutical compositions
IL123740A0 (en) *	1997-03-28	1998-10-30	Pfizer	NK-1 receptor antagonists for the treatment of delayed emesis
NZ329807A (en) *	1997-04-23	2000-07-28	Pfizer	NK-1 receptor antagonists and P receptor antagonists 2-Diarylmethyl-3-amino-1-azabicyclo[2.2.2]octane derivatives and amino substituted N-containing rings as agents for treating irritable bowel syndrome
IL136950A0 (en) *	1998-03-19	2001-06-14	Takeda Chemical Industries Ltd	Heterocyclic compounds, their production and use
US6387925B1 (en) *	1999-06-01	2002-05-14	Pfizer Inc.	Polymorphs of a crystalline azo-bicyclo (2.2.2) oct-3-yl amine citrate and their pharmaceutical compositions
US6255320B1 (en) *	1999-06-01	2001-07-03	Pfizer Inc.	Polymorphs of a crystalline azo-bicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
US6262067B1 (en) *	1999-06-22	2001-07-17	Pfizer Inc.	Polymorphs of a crystalline azo-bicyclo 2,2,2 OCT-3-yl amine dihydrochloride and their pharmaceutical compositions
CA2324116A1 (en) *	1999-10-25	2001-04-25	Susan Beth Sobolov-Jaynes	Nk-1 receptor antagonists and eletriptan for the treatment of migraine
US7163949B1 (en)	1999-11-03	2007-01-16	Amr Technology, Inc.	4-phenyl substituted tetrahydroisoquinolines and use thereof
JP4907818B2 (en)	1999-11-03	2012-04-04	エーエムアールテクノロジーインコーポレイテッド	Aryl and heteroaryl substituted tetrahydroisoquinolines and their use to prevent reuptake of norepinephrine, dopamine and serotonin
IL142810A0 (en) *	2000-05-03	2002-03-10	Pfizer Prod Inc	Pharmaceutical uses for fluoroalkoxybenzylamino derivatives of nitrogen containing heterocycles
CN100430401C (en)	2000-07-11	2008-11-05	Amr科技公司	Novel 4-phenyl substituted tetrahydroisoquinolines and therapeutic use thereof
US20020049211A1 (en) *	2000-09-06	2002-04-25	Sobolov-Jaynes Susan Beth	Combination treatment for depression and anxiety
EP1192952A3 (en) *	2000-09-28	2003-03-26	Pfizer Products Inc.	Combination, for treating depression and anxiety, containing an NK-3 receptor antagonist and a CNS penetrant NK-1 receptor antagonist
CA2448722A1 (en) *	2001-07-20	2003-02-06	Pfizer Products Inc.	Use of nk-1 receptor antagonists to modify unwanted behavior in dogs, cats and horses
US6686507B2 (en)	2002-03-06	2004-02-03	Pfizer Inc	Purification of 2-methoxy-5-trifluoromethoxybenzaldehyde
GB0220581D0 (en) *	2002-09-04	2002-10-09	Novartis Ag	Organic Compound
US6861526B2 (en)	2002-10-16	2005-03-01	Pfizer Inc.	Process for the preparation of (S,S)-cis-2-benzhydryl-3-benzylaminoquinuclidine
ZA200505733B (en) *	2003-01-21	2006-10-25	Yeda Res & Dev	COP 1 for treatment of inflammatory bowel diseases
US20050112695A1 (en) *	2003-10-27	2005-05-26	Meyer Donald W.	Method of detecting bovine spongiform encephalopathy
ES2347152T3 (en) *	2003-11-26	2010-10-26	Pfizer Products Inc.	DERIVATIVES OF AMINOPIRAZOL AS INHIBITORS OF GSK-3.
KR100834232B1 (en) *	2004-01-30	2008-05-30	화이자 프로덕츠 인크.	Antimicrobial preservatives to achieve multi-dose formulation using beta-cyclodextrins for liquid dosage forms
RU2337685C2 (en) *	2004-01-30	2008-11-10	Пфайзер Продактс Инк.	Antagonists of neurokininic receptor nk-1 for anesthesia recovery
CA2554360A1 (en)	2004-02-02	2005-08-18	Pfizer Products Inc.	Process for preparation of 1-(2s,3s)-2-benzhydryl-n-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amine
RU2388751C2 (en)	2004-07-15	2010-05-10	Амр Текнолоджи, Инк.	Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof for inhibiting norepinephrine, dopamine and serotonin reuptake
ES2382814T3 (en)	2005-05-17	2012-06-13	Merck Sharp & Dohme Ltd.	Cis-4 - [(4-chlorophenyl) sulfonyl] -4- (2,5-difluorophenyl) cyclohexanopropanoic acid for cancer treatment
EA019115B1 (en)	2005-07-15	2014-01-30	Олбани Молекьюлар Рисерч, Инк.	Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
CN101277960A (en)	2005-09-29	2008-10-01	默克公司	Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
GB0603041D0 (en)	2006-02-15	2006-03-29	Angeletti P Ist Richerche Bio	Therapeutic compounds
EP2698157B1 (en)	2006-09-22	2015-05-20	Merck Sharp & Dohme Corp.	Method of treatment using fatty acid synthesis inhibitors
US20110218176A1 (en)	2006-11-01	2011-09-08	Barbara Brooke Jennings-Spring	Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development
CN101190330A (en)	2006-11-30	2008-06-04	深圳市鼎兴生物医药技术开发有限公司	Application of cholinesterase in antagonizing tachykinin drugs
EP2805945B1 (en)	2007-01-10	2019-04-03	MSD Italia S.r.l.	Amide substituted indazoles as poly(ADP-ribose)polymerase (PARP) inhibitors
KR20090112722A (en)	2007-01-24	2009-10-28	글락소 그룹 리미티드	3,5-diamino-6- (2,3-dichlorophenyl) -1,2,4-triazine or R (-)-2,4-diamino-5- (2,3-dichlorophenyl)- Pharmaceutical composition comprising 6-fluoromethyl pyrimidine and NX1
WO2008120653A1 (en)	2007-04-02	2008-10-09	Banyu Pharmaceutical Co., Ltd.	Indoledione derivative
US8389553B2 (en)	2007-06-27	2013-03-05	Merck Sharp & Dohme Corp.	4-carboxybenzylamino derivatives as histone deacetylase inhibitors
AU2009222122A1 (en)	2008-03-03	2009-09-11	Tiger Pharmatech	Tyrosine kinase inhibitors
US9156812B2 (en)	2008-06-04	2015-10-13	Bristol-Myers Squibb Company	Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine
UA105182C2 (en)	2008-07-03	2014-04-25	Ньюрексон, Інк.	Benzoxazines, benzothiazines, and related compounds having nos inhibitory activity
US8691825B2 (en)	2009-04-01	2014-04-08	Merck Sharp & Dohme Corp.	Inhibitors of AKT activity
CA2760837C (en)	2009-05-12	2018-04-03	Albany Molecular Research, Inc.	7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof
WO2010132487A1 (en)	2009-05-12	2010-11-18	Bristol-Myers Squibb Company	CRYSTALLINE FORMS OF (S)-7-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)-4-(3,4-DICHLOROHPHENYL)-1,2,3,4-TETRAHYDROISOQUINOLINE AND USE THEREOF
KR20120034644A (en)	2009-05-12	2012-04-12	알바니 몰레큘라 리써치, 인크.	Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof
BR112012008849A2 (en)	2009-10-14	2015-09-22	Schering Corp	compound, pharmaceutical composition, and use of a compound
US8999957B2 (en)	2010-06-24	2015-04-07	Merck Sharp & Dohme Corp.	Heterocyclic compounds as ERK inhibitors
US8518907B2 (en)	2010-08-02	2013-08-27	Merck Sharp & Dohme Corp.	RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA)
EP3587574B1 (en)	2010-08-17	2022-03-16	Sirna Therapeutics, Inc.	Rna interference mediated inhibition of hepatitis b virus (hbv) gene expression using short interfering nucleic acid (sina)
EP2608669B1 (en)	2010-08-23	2016-06-22	Merck Sharp & Dohme Corp.	NOVEL PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES AS mTOR INHIBITORS
WO2012030685A2 (en)	2010-09-01	2012-03-08	Schering Corporation	Indazole derivatives useful as erk inhibitors
US9242981B2 (en)	2010-09-16	2016-01-26	Merck Sharp & Dohme Corp.	Fused pyrazole derivatives as novel ERK inhibitors
ES2663009T3 (en)	2010-10-29	2018-04-10	Sirna Therapeutics, Inc.	Inhibition of RNA-mediated gene expression using short interference nucleic acids (ANic)
US9351965B2 (en)	2010-12-21	2016-05-31	Merck Sharp & Dohme Corp.	Indazole derivatives useful as ERK inhibitors
EP2699567A1 (en)	2011-04-21	2014-02-26	Merck Sharp & Dohme Corp.	Insulin-like growth factor-1 receptor inhibitors
DK2729147T3 (en)	2011-07-04	2017-12-18	Irbm - Science Park S P A	NK-1 RECEPTOR ANTAGONISTS FOR TREATMENT OF CORNOVA
WO2013063214A1 (en)	2011-10-27	2013-05-02	Merck Sharp & Dohme Corp.	Novel compounds that are erk inhibitors
US20150299696A1 (en)	2012-05-02	2015-10-22	Sirna Therapeutics, Inc.	SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS
BR112015006990A2 (en)	2012-09-28	2017-07-04	Merck Sharp & Dohme	compound, pharmaceutical composition, and use of at least one compound
US20140206667A1 (en)	2012-11-14	2014-07-24	Michela Gallagher	Methods and compositions for treating schizophrenia
PL2925888T3 (en)	2012-11-28	2018-03-30	Merck Sharp & Dohme Corp.	Compositions and methods for treating cancer
WO2014100065A1 (en)	2012-12-20	2014-06-26	Merck Sharp & Dohme Corp.	Substituted imidazopyridines as hdm2 inhibitors
US9540377B2 (en)	2013-01-30	2017-01-10	Merck Sharp & Dohme Corp.	2,6,7,8 substituted purines as HDM2 inhibitors
US20160194368A1 (en)	2013-09-03	2016-07-07	Moderna Therapeutics, Inc.	Circular polynucleotides
WO2018071283A1 (en)	2016-10-12	2018-04-19	Merck Sharp & Dohme Corp.	Kdm5 inhibitors
IL312486B2 (en)	2017-04-10	2025-05-01	Chase Therapeutics Corp	Nk1-antagonist combination and method for treating synucleinopathies
CN106977512B (en) *	2017-05-04	2019-01-01	海门慧聚药业有限公司	The method for preparing the smooth free alkali of horse sieve
ES3009607T3 (en)	2017-06-30	2025-03-27	Chase Therapeutics Corp	Nk-1 antagonist compositions and methods for use in treating depression
EP3706742B1 (en)	2017-11-08	2023-03-15	Merck Sharp & Dohme LLC	Prmt5 inhibitors
WO2019094312A1 (en)	2017-11-08	2019-05-16	Merck Sharp & Dohme Corp.	Prmt5 inhibitors
EP4371613A3 (en)	2018-02-26	2024-07-24	Ospedale San Raffaele S.r.l.	Compounds for use in the treatment of ocular pain
KR102102109B1 (en) *	2018-07-10	2020-04-20	성균관대학교산학협력단	Suppression composition of sodium leak channel comprising N-Benzhydryl Quinuclidine derivatives
EP3833668B1 (en)	2018-08-07	2025-03-19	Merck Sharp & Dohme LLC	Prmt5 inhibitors
MX2021001486A (en)	2018-08-07	2021-07-15	Merck Sharp & Dohme Llc	Prmt5 inhibitors.
US11981701B2 (en)	2018-08-07	2024-05-14	Merck Sharp & Dohme Llc	PRMT5 inhibitors
US20230134843A1 (en)	2020-03-11	2023-05-04	Ospedale San Raffaele S.R.L.	Treatment of stem cell deficiency
AT527172A1 (en)	2023-04-25	2024-11-15	Vetviva Richter Gmbh	maropitant formulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MX18467A (en) *	1988-11-23	1993-07-01	Pfizer	THERAPEUTIC AGENTS OF QUINUCLIDINES
HUT62891A (en) *	1990-06-01	1993-06-28	Pfizer	Process for producing 3-amino-2-arylquinuclidine compounds and pharmaceuticql composition comprising such compounds
DE4026743A1 (en) *	1990-08-24	1992-02-27	Teves Gmbh Alfred	ANTI-BLOCKED BRAKE SYSTEM FOR MOTOR VEHICLES
US5716965A (en) *	1991-05-22	1998-02-10	Pfizer Inc.	Substituted 3-aminoquinuclidines
WO1992021677A1 (en) *	1991-05-31	1992-12-10	Pfizer Inc.	bibNUCLIDINE DERIVATIVES
ATE195867T1 (en) *	1991-09-20	2000-09-15	Glaxo Group Ltd	NEW MEDICAL INDICATION FOR TACHYKININ ANTAGONISTS
GB9218334D0 (en) *	1992-08-28	1992-10-14	Ici Plc	Heterocyclic compounds
US5340826A (en) *	1993-02-04	1994-08-23	Pfizer Inc.	Pharmaceutical agents for treatment of urinary incontinence
US5393762A (en) *	1993-06-04	1995-02-28	Pfizer Inc.	Pharmaceutical agents for treatment of emesis
EP0655246A1 (en) *	1993-11-30	1995-05-31	Pfizer Inc.	Substance P antagonists for the treatment of disorders caused by helicobacter pylori or other spiral urease-positive gram-negative bacteria
US5576317A (en) *	1994-12-09	1996-11-19	Pfizer Inc.	NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis
EP0785198B1 (en) *	1996-01-19	2000-07-05	Lonza Ag	Method for the preparation of optically active 3-hydroxyquinuclidine
US5990125A (en) *	1996-01-19	1999-11-23	Pfizer Inc.	NK-1 receptor antagonists for the treatment of cancer

1992
- 1992-04-28 WO PCT/US1992/003317 patent/WO1992021677A1/en not_active Ceased
- 1992-04-28 RU RU93058555A patent/RU2103269C1/en active Protection Beyond IP Right Term
- 1992-04-28 DK DK92912601.9T patent/DK0587723T3/en active
- 1992-04-28 DE DE69208877T patent/DE69208877T2/en not_active Expired - Lifetime
- 1992-04-28 UA UA93004096A patent/UA27776C2/en unknown
- 1992-04-28 CZ CS923906A patent/CZ281403B6/en not_active IP Right Cessation
- 1992-04-28 ES ES92912601T patent/ES2084361T3/en not_active Expired - Lifetime
- 1992-04-28 HU HU9303393A patent/HU217548B/en active Protection Beyond IP Right Term
- 1992-04-28 EP EP92912601A patent/EP0587723B1/en not_active Expired - Lifetime
- 1992-04-28 JP JP5500353A patent/JPH0733386B2/en not_active Expired - Lifetime
- 1992-04-28 US US08/211,120 patent/US5807867A/en not_active Expired - Lifetime
- 1992-04-28 DE DE9290063U patent/DE9290063U1/en not_active Expired - Lifetime
- 1992-04-28 DE DE200612000066 patent/DE122006000066I2/en active Active
- 1992-04-28 KR KR1019930703649A patent/KR100214905B1/en not_active Expired - Lifetime
- 1992-04-28 BR BR9206073A patent/BR9206073A/en not_active Application Discontinuation
- 1992-04-28 SK SK3906-92A patent/SK390692A3/en not_active IP Right Cessation
- 1992-04-28 AT AT92912601T patent/ATE135006T1/en active
- 1992-04-28 PL PL92301472A patent/PL171379B1/en unknown
- 1992-04-28 AU AU19901/92A patent/AU657552B2/en not_active Expired
- 1992-04-28 DE DE1992608877 patent/DE122006000066I1/en active Pending
- 1992-04-28 CA CA002102179A patent/CA2102179C/en not_active Expired - Lifetime
- 1992-04-28 RO RO93-01581A patent/RO110499B1/en unknown
- 1992-05-05 TW TW081103509A patent/TW204349B/zh not_active IP Right Cessation
- 1992-05-11 AP APAP/P/1992/000384A patent/AP299A/en active
- 1992-05-26 UY UY23422A patent/UY23422A1/en not_active IP Right Cessation
- 1992-05-26 IL IL10200892A patent/IL102008A/en active Protection Beyond IP Right Term
- 1992-05-29 GT GT199200028A patent/GT199200028A/en unknown
- 1992-05-29 ZA ZA923942A patent/ZA923942B/en unknown
- 1992-05-29 PT PT100546A patent/PT100546B/en not_active IP Right Cessation
- 1992-05-29 NZ NZ242956A patent/NZ242956A/en not_active IP Right Cessation
- 1992-05-29 NZ NZ270673A patent/NZ270673A/en not_active IP Right Cessation
- 1992-05-29 MA MA22826A patent/MA22539A1/en unknown
- 1992-05-29 IS IS3871A patent/IS1611B/en unknown
- 1992-05-29 YU YU56492A patent/YU48995B/en unknown
- 1992-05-29 MX MX9202554A patent/MX9202554A/en unknown
- 1992-05-30 EG EG28492A patent/EG19944A/en active
- 1992-05-30 CN CN92104129A patent/CN1048492C/en not_active Expired - Lifetime
- 1992-07-01 IE IE921729A patent/IE72473B1/en not_active IP Right Cessation
1993
- 1993-11-26 BG BG98248A patent/BG61694B1/en unknown
- 1993-11-29 FI FI935297A patent/FI114475B/en not_active IP Right Cessation
- 1993-11-29 NO NO934312A patent/NO302701B1/en not_active IP Right Cessation
- 1993-11-30 OA OA60442A patent/OA09867A/en unknown
1994
- 1994-10-05 JP JP6241456A patent/JP2645225B2/en not_active Expired - Lifetime
1995
- 1995-01-24 US US08/377,552 patent/US6222038B1/en not_active Expired - Lifetime
1996
- 1996-04-19 GR GR960401066T patent/GR3019687T3/en unknown
1997
- 1997-04-30 US US08/846,909 patent/US5939433A/en not_active Expired - Lifetime
2006
- 2006-12-06 LU LU91293C patent/LU91293I2/en unknown
- 2006-12-06 NL NL300250C patent/NL300250I2/en unknown
2007
- 2007-03-09 NO NO2007003C patent/NO2007003I2/en unknown

Also Published As

Publication number	Publication date
HUT70151A (en)	1995-09-28
CN1067428A (en)	1992-12-30
IL102008A0 (en)	1992-12-30
TW204349B (en)	1993-04-21
NO934312D0 (en)	1993-11-29
SK278788B6 (en)	1998-02-04
GR3019687T3 (en)	1996-07-31
BR9206073A (en)	1994-12-06
FI114475B (en)	2004-10-29
NZ242956A (en)	1995-06-27
PT100546B (en)	1999-12-31
US5939433A (en)	1999-08-17
UY23422A1 (en)	1992-11-12
WO1992021677A1 (en)	1992-12-10
BG61694B1 (en)	1998-03-31
DE122006000066I1 (en)	2007-03-22
PL171379B1 (en)	1997-04-30
CN1048492C (en)	2000-01-19
CA2102179A1 (en)	1992-12-01
HU9303393D0 (en)	1994-03-28
MX9202554A (en)	1992-11-01
IE921729A1 (en)	1992-12-02
EP0587723A1 (en)	1994-03-23
AP9200384A0 (en)	1992-07-31
NO2007003I2 (en)	2011-04-18
ATE135006T1 (en)	1996-03-15
AU657552B2 (en)	1995-03-16
DE122006000066I2 (en)	2007-12-06
IS3871A (en)	1992-12-02
ES2084361T3 (en)	1996-05-01
DE69208877T2 (en)	1996-07-25
YU56492A (en)	1995-03-27
BG98248A (en)	1994-07-29
IS1611B (en)	1996-10-18
FI935297L (en)	1993-11-29
US6222038B1 (en)	2001-04-24
NZ270673A (en)	1997-07-27
SK390692A3 (en)	1998-02-04
CZ281403B6 (en)	1996-09-11
NL300250I1 (en)	2007-02-01
HU217548B (en)	2000-02-28
YU48995B (en)	2003-04-30
CA2102179C (en)	1998-10-27
FI935297A0 (en)	1993-11-29
UA27776C2 (en)	2000-10-16
DE9290063U1 (en)	1994-02-24
EP0587723B1 (en)	1996-03-06
LU91293I2 (en)	2007-02-06
OA09867A (en)	1994-08-15
KR100214905B1 (en)	1999-08-02
PT100546A (en)	1993-08-31
NL300250I2 (en)	2007-03-01
MA22539A1 (en)	1992-12-31
NO302701B1 (en)	1998-04-14
ZA923942B (en)	1993-11-29
RO110499B1 (en)	1996-01-30
EG19944A (en)	1997-02-27
JPH06504292A (en)	1994-05-19
JPH0733386B2 (en)	1995-04-12
US5807867A (en)	1998-09-15
DE69208877D1 (en)	1996-04-11
AP299A (en)	1994-01-14
NO934312L (en)	1993-11-29
JP2645225B2 (en)	1997-08-25
GT199200028A (en)	1993-11-20
IL102008A (en)	1995-12-08
NO2007003I1 (en)	2007-03-26
IE72473B1 (en)	1997-04-23
JPH07285965A (en)	1995-10-31
AU1990192A (en)	1993-01-08
RU2103269C1 (en)	1998-01-27
CZ390692A3 (en)	1994-02-16

Publication	Publication Date	Title
DK0587723T3 (en)	1996-04-01	quinuclidine derivatives
FI924160A7 (en)	1993-03-19	BENZANE DERIVATIVES
FI935726A7 (en)	1993-12-20	Azanorbornane derivatives
FI924159L (en)	1993-03-19	BENZANE DERIVATIVES
NO922182L (en)	1992-12-04	CRYSTALLINIC OXATATOLAN DERIVATIVES
FI933067A7 (en)	1993-09-02	ABSORPTIONSPRODUKT MED SNABBT FUNGERANDE ABSORBERANDE INNEDEL I FLERA SKIKT
FI925422L (en)	1993-05-30	Indolopyrrolocarbazole derivative
FI921262L (en)	1992-09-26	4-ARYLTHIAZOLE OR 4-ARYLIMIDAZOLE DERIVATIVES
NO924890L (en)	1993-06-21	imidazopyridines
FI925763L (en)	1993-06-21	FUNGICIDA 2-IMIDAZOLIN-5-ON- OCH 2-IMIDAZOLIN-5-THION DERIVATIVES
FI923726L (en)	1993-02-24	SULFATERADE GLYCOSAMINOGLYCANOID DERIVATIVES
FI930345L (en)	1993-01-27	FOERFARANDE FOER FRAMSTAELLNING AV RENAT ACRYLAMIDOSULPHONSYRAMONE DERIVATIVES
FI923342L (en)	1993-01-25	PLEUROMUTILINE COMPLEX
FI935243L (en)	1994-01-11	PYRIDONECARBOXYL DERIVATIVES
TR26336A (en)	1995-03-15	SUBSTITUTED PIRAZOLINE DERIVATIVES
FI925314A7 (en)	1993-05-27	Cephalosporin derivative
DE69222599D1 (en)	1997-11-13	Cephalosporin derivatives
FI920394A7 (en)	1992-08-02	3-quinuclidine derivatives
DE59207540D1 (en)	1997-01-02	RESOLVER
MX9206710A (en)	1993-05-01	PIRIDINOL DERIVATIVES
FI924145L (en)	1993-03-18	3-CYCLOALKYLPROP-2-ENAMIDER DERIVATIVES
FI921597A7 (en)	1992-12-04	MAETNING AV EN HISSKORGS POSITION MED HJAELP AV ULTRALJUD
FI942070A7 (en)	1994-05-05	Nitroxyalkylamide derivatives
FI933346A7 (en)	1993-07-26	AMINOALKYLPYRROLIDINEYLTHIOCARBAPENEM DERIVATIVES
FI935293A7 (en)	1993-11-29	PROPENSY DERIVATIVES